approval
saveDEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalMETHYLPREDNISOLONE ACETATE — FDA approvalApr 10, 2026 · 224d ago
- approvalMETHYLPREDNISOLONE ACETATE — FDA approvalJan 20, 2026 · 304d ago
- approvalMETHYLPREDNISOLONE ACETATE — FDA approvalJan 20, 2026 · 304d ago
- approvalDEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approvalNov 4, 2025 · 381d ago
- approvalMETHYLPREDNISOLONE ACETATE — FDA approvalFeb 12, 2025 · 646d ago
- approvalMETHYLPREDNISOLONE ACETATE — FDA approvalFeb 12, 2025 · 646d ago
- approvalDEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approvalJun 5, 2024 · 898d ago
- approvalDEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approvalDec 20, 2023 · 1066d ago
same company · ±60 days · 5
- approvalIDARUBICIN HYDROCHLORIDE: IDARUBICIN HYDROCHLORIDE — FDA approvalFeb 10, 2021
- approvalALDACTAZIDE: ALDACTAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalFeb 19, 2021
- approvallorlatinib: LORBRENA (LORLATINIB) — FDA approvalFeb 26, 2021
- approvallorlatinib: LORBRENA (LORLATINIB) — FDA approvalMar 3, 2021
- approvallorlatinib: LORBRENA (LORLATINIB) — FDA approvalJan 22, 2021
comments(0)
5-min edit window · permanent after that